NewGenIvf (NIVF) Net Margin (2024 - 2025)
NewGenIvf (NIVF) reported Net Margin of 541.73% for Q4 2025, down 49912.0% year-over-year from N/an in Q4 2024, and down 141.48% quarter-over-quarter from 1306.14% in Q3 2025.
NewGenIvf (NIVF) Net Margin (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has 2 years of Net Margin data on file, last reported at 541.73% in Q4 2025.
- Net Margin for Q4 2025 came in at 541.73%, down 49912.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 155.65% (changed N/A YoY), and the FY2025 annual result was 205.84%, up 21456.0% from the prior year.
- Net Margin fell to 541.73% in Q4 2025 per NIVF's latest filing, from 1306.14% in the prior quarter.
- Over five years, Net Margin peaked at 1306.14% in Q3 2025 and troughed at 541.73% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 9.72% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 13.08% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 8.05% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 1.00% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 6.93% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 7.76% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 300.60% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 10.08% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 5.68% |
| 10 | NewGenIvf | - | - | 524,025.00 | -541.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -541.73% |
| Sep 30, 2025 | 1,306.14% |
| Dec 31, 2024 | -42.61% |
| Sep 30, 2024 | -2.06% |